PIM2 is also induced by cisplatin in ovarian cancer cells, and the targeting of the PIM2 kinase by biochemical inhibitors or RNA interference leads to the reduction of cell growth, the decrease of BAD phosphorylation, and the sensitization of the ovarian cancer cells to drug-induced apoptosis 54. The gene discussed is PIM2; the disease is ovarian carcinoma.